GOODRX HOLDINGS INC-CLASS A (GDRX) Stock Fundamental Analysis
NASDAQ:GDRX - Nasdaq - US38246G1085 - Common Stock - Currency: USD
We assign a fundamental rating of 6 out of 10 to GDRX. GDRX was compared to 37 industry peers in the Health Care Technology industry. GDRX has only an average score on both its financial health and profitability. A decent growth rate in combination with a cheap valuation! Better keep an eye on GDRX. These ratings could make GDRX a good candidate for value investing.
1. Profitability
1.1 Basic Checks
GDRX had positive earnings in the past year.
GDRX had a positive operating cash flow in the past year.
GDRX had negative earnings in 4 of the past 5 years.
GDRX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
GDRX has a better Return On Assets (1.18%) than 86.49% of its industry peers.
GDRX's Return On Equity of 2.26% is amongst the best of the industry. GDRX outperforms 86.49% of its industry peers.
Looking at the Return On Invested Capital, with a value of 4.11%, GDRX belongs to the top of the industry, outperforming 86.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 2.26% | ||
| ROIC | 4.11% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
GDRX's Profit Margin of 2.07% is amongst the best of the industry. GDRX outperforms 86.49% of its industry peers.
In the last couple of years the Profit Margin of GDRX has declined.
Looking at the Operating Margin, with a value of 8.31%, GDRX belongs to the top of the industry, outperforming 83.78% of the companies in the same industry.
GDRX's Operating Margin has declined in the last couple of years.
GDRX has a Gross Margin of 93.91%. This is amongst the best in the industry. GDRX outperforms 100.00% of its industry peers.
GDRX's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 8.31% | ||
| PM (TTM) | 2.07% | ||
| GM | 93.91% |
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), GDRX is destroying value.
Compared to 1 year ago, GDRX has less shares outstanding
The number of shares outstanding for GDRX remains at a similar level compared to 5 years ago.
GDRX has a better debt/assets ratio than last year.
2.2 Solvency
GDRX has an Altman-Z score of 1.35. This is a bad value and indicates that GDRX is not financially healthy and even has some risk of bankruptcy.
GDRX has a Altman-Z score (1.35) which is comparable to the rest of the industry.
The Debt to FCF ratio of GDRX is 4.33, which is a neutral value as it means it would take GDRX, 4.33 years of fcf income to pay off all of its debts.
GDRX has a better Debt to FCF ratio (4.33) than 72.97% of its industry peers.
A Debt/Equity ratio of 0.67 indicates that GDRX is somewhat dependend on debt financing.
GDRX's Debt to Equity ratio of 0.67 is on the low side compared to the rest of the industry. GDRX is outperformed by 67.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 4.33 | ||
| Altman-Z | 1.35 |
ROIC/WACC0.37
WACC11.07%
2.3 Liquidity
A Current Ratio of 5.32 indicates that GDRX has no problem at all paying its short term obligations.
GDRX's Current ratio of 5.32 is amongst the best of the industry. GDRX outperforms 91.89% of its industry peers.
GDRX has a Quick Ratio of 5.32. This indicates that GDRX is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of GDRX (5.32) is better than 91.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.32 | ||
| Quick Ratio | 5.32 |
3. Growth
3.1 Past
GDRX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 17.86%, which is quite good.
The earnings per share for GDRX have been decreasing by -24.47% on average. This is quite bad
Looking at the last year, GDRX shows a small growth in Revenue. The Revenue has grown by 5.59% in the last year.
Measured over the past years, GDRX shows a quite strong growth in Revenue. The Revenue has been growing by 15.34% on average per year.
EPS 1Y (TTM)17.86%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
Revenue 1Y (TTM)5.59%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.99%
3.2 Future
The Earnings Per Share is expected to grow by 23.78% on average over the next years. This is a very strong growth
Based on estimates for the next years, GDRX will show a small growth in Revenue. The Revenue will grow by 6.00% on average per year.
EPS Next Y24.45%
EPS Next 2Y20.89%
EPS Next 3Y17.54%
EPS Next 5Y23.78%
Revenue Next Year3.73%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y6%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
GDRX is valuated correctly with a Price/Earnings ratio of 14.18.
Based on the Price/Earnings ratio, GDRX is valued cheaply inside the industry as 94.59% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 28.22. GDRX is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 11.40, the valuation of GDRX can be described as very reasonable.
100.00% of the companies in the same industry are more expensive than GDRX, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 20.86. GDRX is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 11.4 |
4.2 Price Multiples
GDRX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. GDRX is cheaper than 86.49% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GDRX indicates a rather cheap valuation: GDRX is cheaper than 89.19% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.81 | ||
| EV/EBITDA | 13.47 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
GDRX has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as GDRX's earnings are expected to grow with 17.54% in the coming years.
PEG (NY)0.58
PEG (5Y)N/A
EPS Next 2Y20.89%
EPS Next 3Y17.54%
5. Dividend
5.1 Amount
GDRX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:GDRX (5/2/2025, 8:00:01 PM)
4.68
+0.04 (+0.86%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners61.65%
Inst Owner Change0.07%
Ins Owners10.96%
Ins Owner Change1.94%
Market Cap1.80B
Analysts75.65
Price Target6.76 (44.44%)
Short Float %5.25%
Short Ratio3.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-8.84%
Min EPS beat(2)-9.04%
Max EPS beat(2)-8.64%
EPS beat(4)1
Avg EPS beat(4)-5.84%
Min EPS beat(4)-10.15%
Max EPS beat(4)4.48%
EPS beat(8)5
Avg EPS beat(8)3.86%
EPS beat(12)9
Avg EPS beat(12)18.46%
EPS beat(16)10
Avg EPS beat(16)12.83%
Revenue beat(2)0
Avg Revenue beat(2)-2.36%
Min Revenue beat(2)-2.56%
Max Revenue beat(2)-2.16%
Revenue beat(4)0
Avg Revenue beat(4)-1.91%
Min Revenue beat(4)-2.56%
Max Revenue beat(4)-1.06%
Revenue beat(8)0
Avg Revenue beat(8)-2.11%
Revenue beat(12)2
Avg Revenue beat(12)-1.29%
Revenue beat(16)2
Avg Revenue beat(16)-1.51%
PT rev (1m)-0.33%
PT rev (3m)-7.31%
EPS NQ rev (1m)0.88%
EPS NQ rev (3m)-3.93%
EPS NY rev (1m)1.16%
EPS NY rev (3m)0.71%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-0.5%
Revenue NY rev (1m)-0.15%
Revenue NY rev (3m)-0.29%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 14.18 | ||
| Fwd PE | 11.4 | ||
| P/S | 2.27 | ||
| P/FCF | 15.81 | ||
| P/OCF | 9.76 | ||
| P/B | 2.48 | ||
| P/tB | 13.1 | ||
| EV/EBITDA | 13.47 |
EPS(TTM)0.33
EY7.05%
EPS(NY)0.41
Fwd EY8.78%
FCF(TTM)0.3
FCFY6.32%
OCF(TTM)0.48
OCFY10.24%
SpS2.07
BVpS1.89
TBVpS0.36
PEG (NY)0.58
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 1.18% | ||
| ROE | 2.26% | ||
| ROCE | 5.21% | ||
| ROIC | 4.11% | ||
| ROICexc | 6.38% | ||
| ROICexgc | 22.8% | ||
| OM | 8.31% | ||
| PM (TTM) | 2.07% | ||
| GM | 93.91% | ||
| FCFM | 14.33% |
ROA(3y)-0.47%
ROA(5y)-4.59%
ROE(3y)-0.98%
ROE(5y)-9.45%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3Y37.95%
ROICexcg growth 5Y-33.14%
ROICexc growth 3Y52.2%
ROICexc growth 5Y-28.33%
OM growth 3Y66.59%
OM growth 5Y-25.41%
PM growth 3YN/A
PM growth 5Y-34.38%
GM growth 3Y0.06%
GM growth 5Y-0.52%
F-Score8
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.67 | ||
| Debt/FCF | 4.33 | ||
| Debt/EBITDA | 3.6 | ||
| Cap/Depr | 101.16% | ||
| Cap/Sales | 8.88% | ||
| Interest Coverage | 1.2 | ||
| Cash Conversion | 135.83% | ||
| Profit Quality | 692.77% | ||
| Current Ratio | 5.32 | ||
| Quick Ratio | 5.32 | ||
| Altman-Z | 1.35 |
F-Score8
WACC11.07%
ROIC/WACC0.37
Cap/Depr(3y)84.93%
Cap/Depr(5y)109.87%
Cap/Sales(3y)7.84%
Cap/Sales(5y)6.93%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.86%
EPS 3Y0%
EPS 5Y-24.47%
EPS Q2Q%12.5%
EPS Next Y24.45%
EPS Next 2Y20.89%
EPS Next 3Y17.54%
EPS Next 5Y23.78%
Revenue 1Y (TTM)5.59%
Revenue growth 3Y2.06%
Revenue growth 5Y15.34%
Sales Q2Q%0.99%
Revenue Next Year3.73%
Revenue Next 2Y5.05%
Revenue Next 3Y5.62%
Revenue Next 5Y6%
EBIT growth 1Y347.41%
EBIT growth 3Y70.01%
EBIT growth 5Y-13.97%
EBIT Next Year38.3%
EBIT Next 3Y18.47%
EBIT Next 5Y13.9%
FCF growth 1Y37.59%
FCF growth 3Y-7.68%
FCF growth 5Y7.91%
OCF growth 1Y32.97%
OCF growth 3Y0.94%
OCF growth 5Y17.16%